Herantis Pharma Oyj (HEL:HRTIS)

Herantis Pharma Oyj Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-4.94	0.28	-9.32	-12.77	-9.15
Other Amortization	-	-	0.16	2.72	0.93
Other Operating Activities	-0.04	-5.13	0.24	-	-0
Change in Accounts Receivable	-0.18	-0.02	-0.1	0.04	0.05
Change in Other Net Operating Assets	-1.39	0.23	0.08	0.07	-0.38
Operating Cash Flow	-6.55	-4.64	-8.94	-9.93	-8.56
Sale of Property, Plant & Equipment	-	-	-	-	0
Investment in Securities	-0.47	-	-	-	-
Other Investing Activities	-	0.61	-0.21	-	-
Investing Cash Flow	-0.47	0.61	-0.21	-	0
Long-Term Debt Issued	2.16	-	-	-	-
Short-Term Debt Repaid	-0.01	-0.01	-0.15	-0.01	-0.01
Total Debt Repaid	-0.01	-0.01	-0.15	-0.01	-0.01
Net Debt Issued (Repaid)	2.15	-0.01	-0.15	-0.01	-0.01
Issuance of Common Stock	-	4.51	8.71	4.04	14.89
Financing Cash Flow	2.15	4.5	8.56	4.03	14.88
Net Cash Flow	-4.87	0.47	-0.59	-5.9	6.33
Free Cash Flow	-6.55	-4.64	-8.94	-9.93	-8.56
Free Cash Flow Per Share	-0.33	-0.27	-0.61	-0.97	-1.16
Cash Interest Paid	0.01	0.02	1.09	0.31	1.08
Levered Free Cash Flow	-4.64	0.26	-4.76	-5.13	-4.5
Unlevered Free Cash Flow	-4.63	0.27	-4.72	-5.09	-4.45
Change in Net Working Capital	1.49	-0.17	-0.12	0.02	0.34

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.